These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 22542739)

  • 21. Specific binding of 125I-hippocampal cholinergic neurostimulating peptide (HCNP) to rat brain membranes: characterization and regional distribution.
    Morishita M; Otsuka Y; Matsukawa N; Suzuki H; Nakazawa H; Maki M; Katou H; Ueda R; Ojika K
    Brain Res; 2003 Mar; 965(1-2):194-202. PubMed ID: 12591138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of acetylcholine in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice.
    Kondo-Takuma Y; Mizuno M; Tsuda Y; Madokoro Y; Suzuki K; Sato T; Takase H; Uchida Y; Adachi KI; Hida H; Borlongan CV; Matsukawa N
    Sci Rep; 2021 Nov; 11(1):22072. PubMed ID: 34764402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies.
    Mitake S; Ojika K; Katada E; Otsuka Y; Matsukawa N; Fujimori O
    Neuropathol Appl Neurobiol; 1995 Feb; 21(1):35-40. PubMed ID: 7770119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuronal distribution and subcellular localization of HCNP-like immunoreactivity in rat small intestine.
    Katada E; Ojika K; Mitake S; Ueda R
    J Neurocytol; 2000 Mar; 29(3):199-207. PubMed ID: 11428049
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction of glutamatergic activity through cholinergic dysfunction in the hippocampus of hippocampal cholinergic neurostimulating peptide precursor protein knockout mice.
    Suzuki K; Ohi Y; Sato T; Tsuda Y; Madokoro Y; Mizuno M; Adachi K; Uchida Y; Haji A; Ojika K; Matsukawa N
    Sci Rep; 2022 Nov; 12(1):19161. PubMed ID: 36357544
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An atypical role for collapsin response mediator protein 2 (CRMP-2) in neurotransmitter release via interaction with presynaptic voltage-gated calcium channels.
    Brittain JM; Piekarz AD; Wang Y; Kondo T; Cummins TR; Khanna R
    J Biol Chem; 2009 Nov; 284(45):31375-90. PubMed ID: 19755421
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Demonstration of the biological activity of peptide fragments related to human and rat hippocampal cholinergic neurostimulating peptide (HCNP).
    Ojika K; Ueki Y; Mitake S; Tsugu Y; Otsuka Y; Katada E
    Neurosci Lett; 1996 Sep; 215(2):127-30. PubMed ID: 8888012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer disease.
    Maki M; Matsukawa N; Yuasa H; Otsuka Y; Yamamoto T; Akatsu H; Okamoto T; Ueda R; Ojika K
    J Neuropathol Exp Neurol; 2002 Feb; 61(2):176-85. PubMed ID: 11853019
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Demonstration and characterization of hippocampal cholinergic neurostimulating peptide (HCNP) processing enzyme activity in rat hippocampus.
    Otsuka Y; Ojika K
    Neurochem Res; 1996 Mar; 21(3):369-76. PubMed ID: 9139244
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The unsolved mystery of hippocampal cholinergic neurostimulating peptide: A potent cholinergic regulator.
    Cho JY; Matsukawa N
    Brain Circ; 2021; 7(1):29-32. PubMed ID: 34084974
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The emerging cardioinhibitory role of the hippocampal cholinergic neurostimulating peptide.
    Angelone T; Goumon Y; Cerra MC; Metz-Boutigue MH; Aunis D; Tota B
    J Pharmacol Exp Ther; 2006 Jul; 318(1):336-44. PubMed ID: 16608915
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in the expression of collapsin response mediator protein-2 during synaptic plasticity in the mouse hippocampus.
    Kadoyama K; Matsuura K; Nakamura-Hirota T; Takano M; Otani M; Matsuyama S
    J Neurosci Res; 2015 Nov; 93(11):1684-92. PubMed ID: 26250894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hippocampal Cholinergic Neurostimulating Peptide Suppresses Acetylcholine Synthesis in T Lymphocytes.
    Saito Y; Mashimo M; Nobeyama A; Murakami K; Fujii T
    Biol Pharm Bull; 2018; 41(10):1611-1614. PubMed ID: 30270332
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Membrane association of presynaptic cytomatrix protein bassoon.
    Sanmartí-Vila L; tom Dieck S; Richter K; Altrock W; Zhang L; Volknandt W; Zimmermann H; Garner CC; Gundelfinger ED; Dresbach T
    Biochem Biophys Res Commun; 2000 Aug; 275(1):43-6. PubMed ID: 10944438
    [TBL] [Abstract][Full Text] [Related]  

  • 35. NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro.
    Ojika K; Tsugu Y; Mitake S; Otsuka Y; Katada E
    Brain Res Dev Brain Res; 1998 Mar; 106(1-2):173-80. PubMed ID: 9555001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Purification and structural analysis of hippocampal cholinergic neurostimulating peptide.
    Ojika K; Kojima S; Ueki Y; Fukushima N; Hayashi K; Yamamoto M
    Brain Res; 1992 Feb; 572(1-2):164-71. PubMed ID: 1611510
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of neuroplastin and synaptic marker protein expression in acute and cultured organotypic hippocampal slices from rat.
    Buckby LE; Mummery R; Crompton MR; Beesley PW; Empson RM
    Brain Res Dev Brain Res; 2004 May; 150(1):1-7. PubMed ID: 15126032
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distribution of hippocampal cholinergic neurostimulating peptide (HCNP) immunoreactivity in the central nervous system of the rat.
    Mitake S; Ojika K; Katada E; Otsuka Y; Matsukawa N; Fujimori O
    Brain Res; 1996 Jan; 706(1):57-70. PubMed ID: 8720492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Demonstration of deacetylated hippocampal cholinergic neurostimulating peptide and its precursor protein in rat tissues.
    Ojika K; Katada E; Tohdoh N; Mitake S; Otsuka Y; Matsukawa N; Tsugu Y
    Brain Res; 1995 Dec; 701(1-2):19-27. PubMed ID: 8925283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chronic fluoxetine treatment increases expression of synaptic proteins in the hippocampus of the ovariectomized rat: role of BDNF signalling.
    O'Leary OF; Wu X; Castren E
    Psychoneuroendocrinology; 2009 Apr; 34(3):367-81. PubMed ID: 18977602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.